8EJF image
Deposition Date 2022-09-16
Release Date 2023-06-07
Last Version Date 2025-06-04
Entry Detail
PDB ID:
8EJF
Keywords:
Title:
Structure of lineage V Lassa virus glycoprotein complex (strain Soromba-R)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.72 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Glycoprotein GP1
Gene (Uniprot):GPC
Mutagens:H207C,L257R,L258R
Chain IDs:A, C (auth: B), E (auth: C)
Chain Length:406
Number of Molecules:3
Biological Source:Lassa mammarenavirus
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Glycoprotein GP2
Gene (Uniprot):GPC
Mutagens:H207C, E328P, G359C
Chain IDs:B (auth: a), D (auth: b), F (auth: c)
Chain Length:406
Number of Molecules:3
Biological Source:Lassa mammarenavirus
Ligand Molecules
Primary Citation
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.
Cell Rep 42 112524 112524 (2023)
PMID: 37209096 DOI: 10.1016/j.celrep.2023.112524

Abstact

Lassa fever is an acute hemorrhagic fever caused by the zoonotic Lassa virus (LASV). The LASV glycoprotein complex (GPC) mediates viral entry and is the sole target for neutralizing antibodies. Immunogen design is complicated by the metastable nature of recombinant GPCs and the antigenic differences among phylogenetically distinct LASV lineages. Despite the sequence diversity of the GPC, structures of most lineages are lacking. We present the development and characterization of prefusion-stabilized, trimeric GPCs of LASV lineages II, V, and VII, revealing structural conservation despite sequence diversity. High-resolution structures and biophysical characterization of the GPC in complex with GP1-A-specific antibodies suggest their neutralization mechanisms. Finally, we present the isolation and characterization of a trimer-preferring neutralizing antibody belonging to the GPC-B competition group with an epitope that spans adjacent protomers and includes the fusion peptide. Our work provides molecular detail information on LASV antigenic diversity and will guide efforts to design pan-LASV vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures